Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer

Author： Nakanishi Ryota   Harada Jun   Tuul Munkhbold   Zhao Yan   Ando Koji   Saeki Hiroshi   Oki Eiji   Ohga Takefumi   Kitao Hiroyuki   Kakeji Yoshihiro   Maehara Yoshihiko  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.18, Iss.6, 2013-12, pp. : 1042-1048

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer

By Soeda Hiroshi   Shimodaira Hideki   Watanabe Mika   Suzuki Takao   Gamoh Makio   Mori Takahiro   Komine Keigo   Iwama Noriyuki   Kato Shunsuke   Ishioka Chikashi  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 670-677

Springer Publishing Company

Access to resources Recommend Favorite

KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review

By Shigaki Hironobu   Baba Yoshifumi   Watanabe Masayuki   Miyake Keisuke   Murata Asuka   Iwagami Shiro   Ishimoto Takatsugu   Iwatsuki Masaaki   Yoshida Naoya   Baba Hideo  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 485-491

Springer Publishing Company

Access to resources Recommend Favorite

KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications

By Italiano Antoine  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1429-1434

Springer Publishing Company

Access to resources Recommend Favorite

Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung Adenocarcinomas

By Sonobe Makoto   Kobayashi Masashi   Ishikawa Masashi   Kikuchi Ryutaro   Nakayama Ei   Takahashi Tsuyoshi   Menju Toshi   Takenaka Kazumasa   Miyahara Ryo   Huang Cheng-Long   Okubo Kenichi   Bando Toru   Date Hiroshi  

Annals of Surgical Oncology, Vol. 19, Iss. 3, 2012-07 ,pp. : 347-354

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma

By Spindler Karen-Lise G.   Sorensen Morten M.   Pallisgaard Niels   Andersen Rikke F.   Havelund Birgitte M.   Ploen John   Lassen Ulrik   Jakobsen Anders K. M.  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 963-970

Informa Healthcare

Access to resources Recommend Favorite